These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 29213125)

  • 1. The role of semaphorins in immune responses and autoimmune rheumatic diseases.
    Nishide M; Kumanogoh A
    Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune changes in various rheumatic diseases].
    Borisova AM
    Ter Arkh; 1986; 58(7):43-6. PubMed ID: 3490009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic apheresis in autoimmune and rheumatic diseases.
    Koo AP
    J Clin Apher; 2000; 15(1-2):18-27. PubMed ID: 10767049
    [No Abstract]   [Full Text] [Related]  

  • 4. Tobacco smoking and autoimmune rheumatic diseases.
    Harel-Meir M; Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases.
    Imamura M; Mukaino A; Takamatsu K; Tsuboi H; Higuchi O; Nakamura H; Abe S; Ando Y; Matsuo H; Nakamura T; Sumida T; Kawakami A; Nakane S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations.
    Sfikakis PP; Tsokos GC
    Clin Exp Rheumatol; 1995; 13(6):763-77. PubMed ID: 8835253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.
    Blanco F; Kalsi J; Ravirajan CT; Speight P; Bradwell AR; Isenberg DA
    Lupus; 1992 Dec; 1(6):391-9. PubMed ID: 1304408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neutrophils in systemic autoimmune diseases.
    Kaplan MJ
    Arthritis Res Ther; 2013 Oct; 15(5):219. PubMed ID: 24286137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of two methods of determination of circulating immune complexes in rheumatic diseases].
    Kositskaia LS; Popova OIa; Lavrova TR; Rodshteĭn OA
    Ter Arkh; 1983; 55(7):18-24. PubMed ID: 6604957
    [No Abstract]   [Full Text] [Related]  

  • 11. Is pregnancy a risk factor for rheumatic autoimmune diseases?
    Marder W; Somers EC
    Curr Opin Rheumatol; 2014 May; 26(3):321-8. PubMed ID: 24646947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classification of rheumatic diseases: impact of developments in immunoassays and immunogenetics.
    Kunkel HG
    Hum Pathol; 1983 Apr; 14(4):288-9. PubMed ID: 6339361
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity in rheumatic disease.
    Padula SJ; Clark RB; Korn JH
    Hum Pathol; 1986 Mar; 17(3):254-63. PubMed ID: 3512415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared symptoms in rheumatic diseases: a blessing or a curse?
    Huizinga TW; Gröndal G
    Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
    De Franceschi L; Bosello S; Scambi C; Biasi D; De Santis M; Caramaschi P; Peluso G; La Verde V; Bambara LM; Ferraccioli G
    Proteomics Clin Appl; 2011 Feb; 5(1-2):78-89. PubMed ID: 21246742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
    Costa O; Pinatel K; Monier JC
    J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
    Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
    Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Semaphorins in Immunopathologies and Rheumatic Diseases.
    Garcia S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis.
    Hudson M; Bernatsky S; Colmegna I; Lora M; Pastinen T; Klein Oros K; Greenwood CMT
    Epigenetics; 2017 Jun; 12(6):433-440. PubMed ID: 28387599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.